Botanical species · safety record

Ipomoea violacea

The EFSA Compendium of Botanicals holds 8 constituent measurements for Ipomoea violacea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ipomoea violacea L.

8Constituent measurements
0Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids3
  • Indole alkaloids2
  • Ergot alkaloids1
  • Saponins1
  • Tannins1

Plant parts

  • Seed7
  • Leaves1

Preparations

  • Solvent extraction4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsSeedSolvent extraction≤ 0.06 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
AlkaloidsSeedSolvent extraction≥ 0.022 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
AlkaloidsLeavesSolvent extractionLC-MSNo resolvable identifier
Ergot alkaloidsSeedSolvent extraction0.0515 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
Indole alkaloidsSeed≥ 0.005 PercentChromatographic testsNo resolvable identifier
Indole alkaloidsSeed≤ 0.079 PercentChromatographic testsNo resolvable identifier
SaponinsSeedNo resolvable identifier
TanninsSeedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Der Marderosian, A., Youngken Jr., H.W. The distribution of indole alkaloids among certain species and varieties of Ipomoea, Rivea and Convolvulus (convolvulaceae). Lloydia, 1966, vol. 29, no. 1, p. 35-42.
  2. Stanescu, Ursula., Riscalcic, Ecaterina., Grigorescu, E. Phytochemical study of Ipomoea violacea seeds. Farmacia (bucharest, romania), 1973, p. 719-728.
  3. Witters, Weldon L. Extraction and identification of clavine and lysergic acid alkaloids from morning glories. Ohio journal of science, 1975, p. 198-201.
  4. WEBER, JM., MA, TS. MICROCHEMICAL INVESTIGATIONS OF MEDICINAL-PLANTS .14. IDENTIFICATION OF ALKALOIDS IN LEAVES OF IPOMOEA-VIOLACEA USING PREPARATIVE THIN-LAYER CHROMATOGRAPHY AND SOLID PROBE MASS-SPECTROMETRY. MIKROCHIMICA ACTA, 1976, vol. 1, no. 2-3, p. 227-242.
  5. Wilkinson, Robert E., Hardcastle, Willis S., McCormick, Cynthia S. Psychotomimetic ergot alkaloid contents of seed from Calonyction muricatum, Jacquemontia tamnifolia, Quamoclit lobata, and Q. sloteri. Botanical gazette (chicago), 1988, p. 107-109. .[coded from abstract].

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue